AVGR Logo

Avinger, Inc. (AVGR) 

NASDAQ
Market Cap
$2.04M
Sector
Healthcare
Industry
Medical—Instruments & Supplies
Rank in Sector
561 of 963
Rank in Industry
32 of 49

Largest Insider Buys in Sector

AVGR Stock Price History Chart

AVGR Stock Performance

About Avinger, Inc.

Avinger, Inc., a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by physicians to treat patients with peripheral arterial disease (PAD) in the United States and internationally. It develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures. The company's lumivascular products comprise Lightbox imaging consoles, as well as the Ocelot family of catheters, which are designed to allow physicians to penetrate a total blockage in an artery; and Pantheris, an image-guided atherectomy device that allows physicians to precisely remove arterial plaque in PAD patients. In addition, its first-generation chronic total occlusion (CTO)-crossing catheters, Wildcat and Kittycat 2, which employs a proprietary design that uses a rotational spinning technique allowing the physician to switch between passive and active modes when navigating across a CTO. Further, the company develops IMAGE-BTK for the treatment of PAD lesions below-the-knee. It markets and sells its products to interventional cardiologists, vascular surgeons, and interventional radiologists. Avinger, Inc. was incorporated in 2007 and is headquartered in Redwood City, California.

Insider Activity of Avinger, Inc.

Over the last 12 months, insiders at Avinger, Inc. have bought $0 and sold $0 worth of Avinger, Inc. stock.

On average, over the past 5 years, insiders at Avinger, Inc. have bought $0 and sold $4,147 worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 100 shares for transaction amount of $100,000 was made by Patel Himanshu (CTO) on 2018‑02‑16.

List of Insider Buy and Sell Transactions, Avinger, Inc.

2023-03-23SaleVice President, Finance
223
0.0027%
$0.81$181-47.68%
2021-11-30Saledirector
184
0.0002%
$0.57$105-84.88%
2021-11-24Saledirector
32
<0.0001%
$0.62$20-85.95%
2020-09-22SaleChief Executive Officer
9,145
0.0137%
$0.33$3,022+212.26%
2020-09-22SaleChief Technology Officer
6,097
0.0091%
$0.33$2,015+212.26%
2020-09-22SaleChief Financial Officer
6,097
0.0091%
$0.33$2,015+212.26%
2020-09-08SaleChief Executive Officer
5,982
0.0084%
$0.40$2,421+139.86%
2020-09-08SaleChief Technology Officer
3,589
0.0051%
$0.40$1,452+139.86%
2020-09-08SaleChief Financial Officer
2,991
0.0042%
$0.40$1,210+139.86%
2018-02-16PurchaseCTO
100
$1,000.00$100,000-6.01%
2017-11-15SaleExecutive Chairman
1M
3.0761%
$0.23$226,293-84.76%
2017-11-14SaleExecutive Chairman
237,794
0.7496%
$0.26$60,733-86.11%
2017-11-13SaleExecutive Chairman
909,168
2.8346%
$0.27$242,475-86.79%
2016-08-16PurchaseChief Executive Officer
114,200
0.5471%
$3.50$399,700-41.89%
2016-08-16PurchaseChief Financial Officer
14,000
0.0671%
$3.50$49,000-41.89%
2016-07-20SaleSr. VP, Sales &amp; Marketing
65,000
0.3662%
$6.28$408,051-55.16%
2016-05-06SaleCTO
20,000
0.1698%
$13.40$268,000-67.10%
2016-05-06Saledirector
18,618
0.1484%
$12.58$234,194-67.10%
2016-04-15SaleExecutive Chairman
150,222
1.2162%
$13.11$1.97M-66.19%
2016-03-11SaleExecutive Chairman
80,000
0.6394%
$11.44$915,056-59.38%

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.